{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:59:35Z","timestamp":1777417175052,"version":"3.51.4"},"reference-count":63,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[1988,5,1]],"date-time":"1988-05-01T00:00:00Z","timestamp":578448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Intelligence &amp; Clinical Pharmacy"],"published-print":{"date-parts":[[1988,5]]},"abstract":"<jats:p>Lisinopril is a new, nonsulfhydryl angiotensin-converting enzyme inhibitor approved for the treatment of hypertension. After oral administration, 25\u201329 percent of the dose is absorbed intact; biotransformation is not required for pharmacological activity. Onset of action occurs one to two hours after administration, with effects still present 24 hours later. The major route of elimination is through renal excretion and an elimination half-life of 12.6 hours has been reported in normotensive individuals. In patients with impaired renal function (creatinine clearance \u2264 30 ml\/min) a longer half-life and accumulation have been observed. Lisinopril 20\u201380 mg\/d has been shown to be as effective as hydrochlorothiazide, nifedipine, and beta-blocking agents in the treatment of essential hypertension. Its efficacy in renovascular hypertension has also been demonstrated. In congestive heart failure (CHF) doses of 2.5\u201320 mg\/d appear to provide hemodynamic effects comparable to those of captopril. Dizziness and cough have been the most frequently reported side effects; rash and proteinuria have also been reported in a small number of patients. Interactions with diuretics, potassium supplements, and possibly with nonsteroidal antiinflammatory agents may occur.<\/jats:p>\n                  <jats:p>Lisinopril appears to be similar in efficacy to other antihypertensive agents in the treatment of essential hypertension and to captopril in the treatment of CHF. Whether lisinopril is safer or more effective than captopril or enalapril in the treatment of hypertension or CHF requires further investigation. Prolonged duration of action of lisinopril allows once daily dosing, unlike captopril for which dosing is required every 8\u201312 hours or enalapril which may necessitate twice daily dosing.<\/jats:p>","DOI":"10.1177\/106002808802200501","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T12:36:33Z","timestamp":1462970193000},"page":"365-372","source":"Crossref","is-referenced-by-count":22,"title":["Lisinopril: A New Angiotensin-Converting Enzyme Inhibitor"],"prefix":"10.1177","volume":"22","author":[{"given":"Graciela M.","family":"Armayor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry M.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1988,5,1]]},"reference":[{"key":"bibr1-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.92"},{"key":"bibr2-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01151.x"},{"key":"bibr3-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1982.tb01990.x"},{"key":"bibr4-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600740330"},{"key":"bibr5-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1982.tb01991.x"},{"key":"bibr6-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1984.119"},{"key":"bibr7-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00017"},{"key":"bibr8-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90694-5"},{"key":"bibr9-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1080\/00365599.1984.11783725"},{"key":"bibr10-106002808802200501","first-page":"149","volume":"71","author":"Sedat YK","year":"1987","journal-title":"S Afr Med J"},{"key":"bibr11-106002808802200501","first-page":"470","volume":"25","author":"Nelson EB","year":"1985","journal-title":"J Clin Pharmacol"},{"key":"bibr12-106002808802200501","first-page":"342","volume":"37","author":"Bussien JP","year":"1985","journal-title":"Curr Ther Res"},{"key":"bibr13-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00012"},{"key":"bibr14-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00013"},{"key":"bibr15-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00021"},{"key":"bibr16-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00019"},{"key":"bibr17-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00020"},{"key":"bibr18-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600750416"},{"key":"bibr19-106002808802200501","first-page":"459","volume":"25","author":"Gomez HJ","year":"1985","journal-title":"J Clin Pharmacol"},{"key":"bibr20-106002808802200501","first-page":"198","volume":"37","author":"Gomez HJ","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"bibr21-106002808802200501","first-page":"471","volume":"25","author":"Beemann B","year":"1985","journal-title":"J Clin Pharmacol"},{"key":"bibr22-106002808802200501","first-page":"544","volume":"26","author":"Gibson TP","year":"1986","journal-title":"J Clin Pharmacol"},{"key":"bibr23-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609951"},{"key":"bibr24-106002808802200501","first-page":"187","volume":"39","author":"Cirillo VJ","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"bibr25-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02337.x"},{"key":"bibr26-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00010"},{"key":"bibr27-106002808802200501","first-page":"975","volume":"14","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"bibr28-106002808802200501","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198631030-00002"},{"key":"bibr29-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00011"},{"key":"bibr30-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00015"},{"key":"bibr31-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.6.2_Pt_2.I193"},{"key":"bibr32-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00003"},{"key":"bibr33-106002808802200501","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-2-222"},{"key":"bibr34-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1080\/00365599.1984.11783728"},{"key":"bibr35-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(85)80090-5"},{"key":"bibr36-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.70.2.271"},{"key":"bibr37-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907193010301"},{"key":"bibr38-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(85)90167-X"},{"key":"bibr39-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301"},{"key":"bibr40-106002808802200501","unstructured":"MCevoy GK, McQuarrie GM, Dipietro-Heydon J, eds. American Hospital Formulary Service Drug Information. 1987 ed. Bethesda: American Society of Hospital Pharmacists, 1987: 798\u2013804."},{"key":"bibr41-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00023"},{"key":"bibr42-106002808802200501","first-page":"592","volume":"27","author":"Ciantz FR","year":"1979","journal-title":"Clin Res"},{"key":"bibr43-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00008"},{"key":"bibr44-106002808802200501","first-page":"204A","volume-title":"Facts and comparisons","author":"Mangini RJ","year":"1987"},{"key":"bibr45-106002808802200501","first-page":"281P","volume":"20","author":"Monis FP","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"bibr46-106002808802200501","first-page":"15","volume":"5","author":"Hansten PD","year":"1985","journal-title":"Drug Int News"},{"key":"bibr47-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00016"},{"key":"bibr48-106002808802200501","first-page":"406A","volume":"34","author":"Rocci ML","year":"1986","journal-title":"Clin Res"},{"key":"bibr49-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.59"},{"key":"bibr50-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)90385-X"},{"key":"bibr51-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.90"},{"key":"bibr52-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600731146"},{"key":"bibr53-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1982.tb02661.x"},{"key":"bibr54-106002808802200501","first-page":"248","volume":"35","author":"Irvin JD","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"bibr55-106002808802200501","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198510050-00001"},{"key":"bibr56-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1982.tb01992.x"},{"key":"bibr57-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2510050309"},{"key":"bibr58-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(84)80054-6"},{"key":"bibr59-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(84)80027-X"},{"key":"bibr60-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6403.1413"},{"key":"bibr61-106002808802200501","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1979.tb127300a.x"},{"key":"bibr62-106002808802200501","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)90361-7"},{"key":"bibr63-106002808802200501","first-page":"107","volume":"10","author":"Stumpe KO","year":"1984","journal-title":"Pract Cardiol"}],"container-title":["Drug Intelligence &amp; Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002808802200501","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002808802200501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:03:53Z","timestamp":1777374233000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002808802200501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1988,5]]}},"alternative-id":["10.1177\/106002808802200501"],"URL":"https:\/\/doi.org\/10.1177\/106002808802200501","relation":{},"ISSN":["0012-6578"],"issn-type":[{"value":"0012-6578","type":"print"}],"subject":[],"published":{"date-parts":[[1988,5]]}}}